gimli
CAPLIPOINT stock analysis context
CAPLIN POINT LAB. Stock Context for AI Screening
CAPLIN POINT LAB LTD. is a small-cap stock in Healthcare. This page summarizes key screening signals for CAPLIN POINT LAB., including recent returns, momentum indicators, valuation ratios, liquidity, and growth metrics. Gimli uses this context to help users ask natural-language stock screening questions across Indian equities.
Ask Gimli about CAPLIPOINTPrice
₹2,028.00
1M return
+15.72%
3M return
+19.85%
Market cap
₹15,415.17 cr
PE
24.49
ROE
+24.05%
RSI
70.79
Turnover
₹18.24 cr
Why it can matter in screens
- Momentum: CAPLIPOINT is above 50DMA, above 200DMA; RSI is 70.79.
- Returns: 1M +15.72%, 3M +19.85%, 6M +5.69%.
- Liquidity: latest turnover is ₹18.24 cr.
- Valuation: PE 24.49, PB 4.25, ROE +24.05%, ROCE +29.75%.
- Growth: 3Y sales CAGR +15.13%, 3Y profit CAGR +21.38%.
Try these prompts
- Analyze CAPLIN POINT LAB. with valuation, momentum and industry peers
- Compare CAPLIPOINT with other Healthcare stocks
- Show small-cap stocks in Healthcare above 50DMA with positive 1M return
- Find Healthcare stocks with improving momentum and reasonable valuation
Related screen ideas
- View Healthcare stocks
- View small-cap stocks
- Find stocks above 50DMA
- Compare CAPLIPOINT with other Healthcare stocks
Data snapshot: 2026-05-22. Not investment advice.